ECC 2013: Late Breaking Clinical Trials: ASPECCT
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
Report by Esther Drain – Cetuximab resulted in a significant improvement in survival in TP53 WT, high-risk Rectal Cancer.
Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) that treatment with adalimumab may be effective for patients with steroid-resistant… read more.
Taken from the European Cancer Congress ( ECCO / ESMO / ESTRO ) from the 27th September – 1st October 2013 in Amsterdam.
by Bruce Sylvester – Cholesterol lowering statin therapy appears to also reduce inflammation associated with gum disease, researchers reported on Oct. 2, 2013 in the Journal of the American… read more.
by Bruce Sylvester – A newly published meta-analysis suggests that influenza vaccination lowers the risk of major adverse cardiovascular events like heart failure or hospitalization for heart attack,… read more.
World Psoriasis Day is 29 October 2013. World Psoriasis Day is held today with the theme “Global access to treatment” to highlight the fact that more than 125… read more.
These activities as good as exercise because they decrease total sedentary time. A spot of DIY or gardening can cut the risk of a heart attack/stroke and prolong… read more.
by Bruce Sylvester – A new meta-analysis of clinical trials evaluating the use of statin medications to prevent heart attacks suggests that the drugs do not threaten short-term… read more.
In part, women and men differ from each other considerably not only in the way they perceive and cope with pain and in various comorbidities. Therapies can also… read more.
Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing cerebral microbleeds, according to a new study. Cerebral microbleeds are a marker of cerebral small… read more.
Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in patients… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.